The role of positron emission tomography in staging of non-small cell lung cancer.
- Published in:
- Targeted Oncology, 2008, v. 3, n. 3, p. 149, doi. 10.1007/s11523-008-0085-6
- By:
- Publication type:
- Article
Works matching IS 17762596 AND DT 2008 AND VI 3 AND IP 3
Results: 9
1
2
Targeted therapies in bronchioloalveolar carcinoma.
- Published in:
- Targeted Oncology, 2008, v. 3, n. 3, p. 197, doi. 10.1007/s11523-008-0088-3
- By:
- Publication type:
- Article
3
Pharmacogenetics in lung cancer for the lay doctor.
- Published in:
- Targeted Oncology, 2008, v. 3, n. 3, p. 161, doi. 10.1007/s11523-008-0083-8
- By:
- Publication type:
- Article
4
Targeted therapy in the management of lung cancer: is there more hype than hope?
- Published in:
- 2008
- By:
- Publication type:
- Editorial
5
Targeted therapy in malignant mesothelioma.
- Published in:
- Targeted Oncology, 2008, v. 3, n. 3, p. 217, doi. 10.1007/s11523-008-0089-2
- By:
- Publication type:
- Article
6
Advanced non-small cell lung cancer therapy: historical and future perspectives.
- Published in:
- Targeted Oncology, 2008, v. 3, n. 3, p. 135, doi. 10.1007/s11523-008-0082-9
- By:
- Publication type:
- Article
7
Update on targeted therapies for small cell carcinoma of the lung.
- Published in:
- Targeted Oncology, 2008, v. 3, n. 3, p. 205, doi. 10.1007/s11523-008-0086-5
- By:
- Publication type:
- Article
8
Antiangiogenic treatments of advanced non-small cell lung cancer.
- Published in:
- Targeted Oncology, 2008, v. 3, n. 3, p. 187, doi. 10.1007/s11523-008-0087-4
- By:
- Publication type:
- Article
9
EGFR tyrosine kinase inhibitors in non-small cell lung cancer patients: how do we interpret the clinical and biomarker data?
- Published in:
- Targeted Oncology, 2008, v. 3, n. 3, p. 173, doi. 10.1007/s11523-008-0084-7
- By:
- Publication type:
- Article